Publicaciones en colaboración con investigadores/as de Wrocław Medical University (14)

2024

  1. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

    eClinicalMedicine, Vol. 71

  2. High prevalence of venous thrombotic events in Cushing’s syndrome: data from ERCUSYN and details in relation to surgery

    European Journal of Endocrinology, Vol. 190, Núm. 1, pp. 75-85

  3. Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications – a HARMONY study

    Leukemia, Vol. 38, Núm. 9, pp. 1929-1937

2023

  1. Identification of novel genetic loci for risk of multiple myeloma by functional annotation

    Leukemia

2021

  1. Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study

    JACC: Heart Failure, Vol. 9, Núm. 2, pp. 146-157

2020

  1. EAACI-Leitlinien zur allergen-spezifischen Immuntherapie: Insektengiftallergie

    Allergologie, Vol. 43, Núm. 5, pp. 176-203

2019

  1. Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma

    Leukemia

2018

  1. Deklaracja medycznego środowiska kardiologicznego, paliatywnego i internistycznego wskazująca na znaczenie opieki paliatywnej w kompleksowej opiece nad chorymi z niewydolnością serca

    Palliative Medicine in Practice

  2. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 4, pp. 765-798

  3. EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 4, pp. 799-815

  4. EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 4, pp. 744-764

  5. The urgent need for a harmonized severity scoring system for acute allergic reactions

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 9, pp. 1792-1800

2017

  1. Cardiovascular efficacy and safety of bococizumab in high-risk patients

    New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

2014

  1. Anaphylaxis: Guidelines from the European Academy of Allergy and Clinical Immunology

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 69, Núm. 8, pp. 1026-1045